Back

Long-term prognostic value of adherence to leisure time physical activity prescription in patients undergoing exercise-based cardiac rehabilitation: an inverse dose-response relationship.

3 September 2019 (09:42 - 09:51)
Organised by:
Congress Presentation Part of: Lipids / Cardiovascular risk prediction / Life style Secondary Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Chiara Mari

Azienda Ospedaliero Universitaria, Modena (Italy)

9 More presentations in this session

Presentation thumbnail
Remnant cholesterol increases the risk for recurrent vascular events independent of ldl-cholesterol in patients with clinical manifest vascular disease.
Ms B. Heidemann (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
The contribution of familial hypercholesterolemia (FH) to premature coronary artery disease decreased by 2-fold between 1998 and 2018 in a founder population with high prevalence of FH
Doctor A. Lauziere (Chicoutimi, CA)
Abstract Slides Video
Presentation thumbnail
Inclisiran-mediated reductions in Lp(a) in the ORION-1 trial
Doctor D. Kallend (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
The effects of climate and air pollutants on heart failure hospitalizations and mortality (CLIMATE-HF Study)
Doctor W. Ngampongpan (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Association between secondhand smoke exposure and diabetes mellitus in 131,724 Korean never smokers using self-reported questionnaire and cotinine: gender differences
Doctor J. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids / Cardiovascular risk prediction / Life style

The Event

Event poster

ESC Congress 2019

3 September 2019 09:42 CET
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources